We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

185 hedge funds and large institutions have $860M invested in SANGAMO THERAPEUTICS INC in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 39

67% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.7M

36% more capital invested

Capital invested by funds: $630M → $860M (+$230M)

4.74% more ownership

Funds ownership: 64.51% → 69.25% (+4.7%)

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.5M
2
BG
Bellevue Group
Switzerland
+$38.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$17.6M
4
BlackRock
BlackRock
New York
+$11.7M
5
N
Nuveen
North Carolina
+$8.41M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.23M
2
State Street
State Street
Massachusetts
-$5.37M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.96M
4
Bank of America
Bank of America
North Carolina
-$2.07M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCIM
151
Meadow Creek Investment Management
Georgia
$18K +$17.9K +1,680 New
CWM
152
Cranbrook Wealth Management
Michigan
$17K – – –
BWP
153
Baldwin Wealth Partners
Massachusetts
$16K – – –
BFEC
154
Benjamin F. Edwards & Company
Missouri
$16K – – –
KBC Group
155
KBC Group
Belgium
$14K – – –
FMP
156
Financial Management Professionals
Texas
$14K +$13.8K +1,300 New
EP
157
Elkfork Partners
Oregon
$14K +$14K +1,320 New
FDCDDQ
158
Federation des caisses Desjardins du Quebec
Quebec, Canada
$12.9K – – –
AF
159
Allworth Financial
California
$11K – – –
CWA
160
Clarus Wealth Advisors
Arizona
$11K – – –
NCM
161
Nelson Capital Management
California
$11K – – –
Nisa Investment Advisors
162
Nisa Investment Advisors
Missouri
$11K +$5.16K +485 +94%
RE
163
RBC Europe
United Kingdom
$10.8K – – –
TAM
164
Tyers Asset Management
Texas
$10K +$10.2K +960 New
APA
165
American Portfolios Advisors
New York
$9.96K – – –
Daiwa Securities Group
166
Daiwa Securities Group
Japan
$8K +$819 +77 +12%
BFC
167
Bedel Financial Consulting
Indiana
$7K – – –
TRCT
168
Tower Research Capital (TRC)
New York
$7K +$4.13K +388 +149%
FHA
169
Flagship Harbor Advisors
Massachusetts
$7K +$7.45K +700 New
CIAS
170
Capital Investment Advisory Services
North Carolina
$6K +$5.32K +500 New
QT
171
Quantbot Technologies
New York
$6K +$6.38K +600 New
PNC Financial Services Group
172
PNC Financial Services Group
Pennsylvania
$5K – – –
FIA
173
FNY Investment Advisers
New York
$5K +$5.46K +513 New
PCM
174
Prelude Capital Management
New York
$4K -$4.52K -425 -54%
WT
175
Whittier Trust
California
$4K – – –
5 6
7
8 9

SGMO Hedge Fund Activity: Q2 2019 in Review

185 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2019, worth a combined $860M — up 36% from $630M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGMO positions and 31 closed out — a net gain of 2 holders — while 76 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $71.5M. The largest seller was Invesco, cutting an estimated $9.23M.

  • 185 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2019, down from 187 in Q1 2019.
  • Funds reported $860M of SANGAMO THERAPEUTICS INC stock for Q2 2019, up 36% quarter-over-quarter.
  • 33 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2019 and 31 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2019 was Wellington Management Group, an estimated $71.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2019 was Invesco, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2019.